Board Meeting17 Mar 2026, 06:14 pm
Shree Ganesh Biotech Closes Trading Window for Securities Dealing Until After Q1 2026 Results
AI Summary
Shree Ganesh Biotech (India) Ltd. has announced the closure of its trading window for dealing in the securities of the company, in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015. The closure will be effective from Wednesday, 1st April, 2026 until 48 hours after the announcement/declaration of Audited Financial Results for the quarter and year ended on 31 March 2026. The date of the proposed Board Meeting for considering the audited financial results for the quarter and year ended on 31 March 2026 will be informed in due course.
Key Highlights
- Shree Ganesh Biotech (India) Ltd. has closed its trading window for securities dealing
- The closure is in accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015
- The trading window will remain closed from Wednesday, 1st April, 2026 till 48 hours after the Q1 2026 results
- The date of the proposed Board Meeting for considering the audited financial results will be informed later
- This is for information and record purposes
Price Impact
More from SHREEGANES